HCM Q4 2016 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

Q4 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$56M-0.9% YoY

Gross Profit

-$5M-8.9% margin

Operating Income

-$15M-27.6% margin

Net Income

$6M10.0% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$747,500

Balance Sheet

Total Assets

$342M

Total Liabilities

$138M

Stockholders' Equity

$184M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$56M	$56M	-0.9%
Gross Profit	-$5M	$25M	-120.1%
Operating Income	-$15M	$93,000	-16626.9%
Net Income	$6M	$3M	+66.1%